Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)

Launched by NORTHWESTERN UNIVERSITY · May 10, 2022

Keywords

ClinConnect Summary

The OPT2MOVE trial is researching ways to help young adults who are cancer survivors increase their physical activity through a mobile health program. This study will last 12 weeks and will test different methods of support, such as e-coaching, having a buddy for encouragement, and mindfulness training (which helps with focus and awareness) to see which ones really help participants move more and feel better. The main goal is to find out which of these support methods makes a noticeable difference in how much exercise participants are doing, as well as how it affects their overall quality of life and other health-related issues like fatigue and sleep quality.

To be eligible for the trial, participants must be young adults aged 18 to 39 who have been diagnosed with nonmetastatic cancer within the last five years and have completed their primary treatment at least three months prior to joining. They should also be able to engage in less than 60 minutes of moderate to vigorous exercise each week and have access to a smartphone and the internet. Participants will work with a buddy for support, and both the young adults and their buddies need to be comfortable sharing their exercise data with the study team. This trial could be a great opportunity for young cancer survivors to improve their health and well-being while participating in a supportive community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • For YACS
• • Diagnosis of nonmetastatic cancer (except non-melanoma skin cancer) within 5 years from the time of screening / study overview session
• • Age Diagnosis of cancer between 18-39 years at time of diagnosis and at time of screening / study overview session
• • Three or more months post-completion of primary treatment (i.e., surgery, chemotherapy, and/or radiation); may still be undergoing endocrine or hormone therapies
• • Score of 0 on two of the Exercise Preparticipation Health Screening Questionnaire items or willingness to obtain medical clearance from a primary care physician or oncologist
• • Self-report engagement in \<60 minutes total each week of MVPA at time of screening / study overview session
• • Ownership of a smartphone that is either an iPhone (version 5 or greater) or an Android (version 5.0 or greater)
• • Internet access
• • Fluency in spoken and written English
• • Willingness, at time of screening / study overview session, to find a Buddy (someone who knows about their cancer and participation in this study and who is willing to participate by supporting them during the 6-month study), if assigned to that condition
• • For "Buddies"
• • Friend, co-worker, caregiver or family member of a participating YACS
• • Age 18 years or older
• • Score of 0 on the Exercise Preparticipation Health Screening Questionnaire or willingness to obtain medical clearance from a primary care physician
• • Ownership of a smartphone that is either an iPhone (version 5 or greater) or an Android (version 5.0 or greater)
• • Internet access
• • Fluency in spoken and written English
• • Willingness to share their Fitbit data with the study team
• Exclusion Criteria:
• • For YACS: Diagnosis of non-melanoma skin cancer
• • Absolute contraindications to exercise (i.e., acute myocardial infarction, severe orthopedic conditions), metastatic disease, or planned elective surgery
• • Currently pregnant or plans to become pregnant in the next 12 months
• • Plans to move out of the United States in next 18 months
• • For YACS: Current enrollment in another dietary or physical activity trial
• • Inability to provide informed consent
• • Prisoners or other detained individuals